期刊文献+

血液分析仪检验急慢性白血病的临床应用 被引量:14

Clinical Application of Hematology Analyzer Tests in Acute and Chronic Leukemia
下载PDF
导出
摘要 目的 探讨血液分析仪检验急慢性白血病的临床应用价值.方法 选取2011年1月~2014年1月我院收治的急慢性白血病患者50例(急性23例,慢性27例),另选取同期于我院进行常规体检的健康志愿者50例为对照组,利用血液分析仪对患者的空腹静脉血样本进行分析,并比较检测结果.结果 由检测结果可知,急慢性白血病患者的血红蛋白分别为33.17±5.39g/L和31.68±4.32g/L,均显著低于对照组;但白细胞及CRP则高于对照组水平,组间比较均有明显差异(P<0.05).但急慢性白血病患者血红蛋白、白细胞计数及C反应蛋白的组间差异均不具有统计学意义(P>0.05).结论 血液分析仪能准确判定急慢性白血病,临床应用价值较高,可作为急慢性白血病的首选检测方法. Objective To explore the clinical applications of hematology analyzer test in acute and chronic leukemia. Methods Patients with acute and chronic leukemia in January 2011 to January2014 in our hospital, 50 cases(23 cases of acute and chronic 27 cases), were selected. Another routine physical examination in the same period, 50 cases of healthy volunteers, were used as control group in our hospital. Using blood analyzer fasting blood samples was for analyze, and the detected result were compared. Results From the test results, acute and chronic leukemia patients hemoglobin were(33.17±5.39)g/L and(31.68±4.32)g/L, were significantly lower than the control group; But WBC and CRP levels in the group were significantly different between the two groups(P <0.05).However, in patients with acute and chronic leukemia hemoglobin, differences of white blood cell count and C-reactive protein group were not statistically significant(P >0.05).Conclusion Hematology analyzer can accurately determine acute and chronic leukemia, can be used as the preferred method for detecting acute and chronic leukemia as a high clinical value.
作者 翁萍
出处 《现代诊断与治疗》 CAS 2014年第23期5290-5291,共2页 Modern Diagnosis and Treatment
关键词 血液分析仪 急慢性白血病 诊断价值 Hematology analyzer Acute and chronic leukemia Diagnostic value
  • 相关文献

参考文献6

二级参考文献43

  • 1秦亚溱,阮国瑞,李金兰,付家瑜,常艳,王卉,李玲娣,刘艳荣,陈珊珊.定量检测WT1基因表达水平在急性髓系白血病微量残留病监测中的意义[J].中华血液学杂志,2005,26(11):649-652. 被引量:22
  • 2陈灏珠,林果为.实用内科学[M].13版.北京:人民卫生出版社,2009:919.
  • 3王平.WT1基因与发病机制[J].前卫医药杂志,1999,10:128-129.
  • 4Algar E.A review of the Wilms' tumor 1 gene (WT1) and its role in hematopoiesis and leukemia.J Hematother Stem Cell Res,2002,11:589-599.
  • 5Sakatani T,Shimazaki C,Hirai H,et al.Early relapse after highdose chemotherapy rescued by tumor-free autologous peripheral blood stem cells in acute lymphoblastic leukemia:importance of monitoring for WT1-mRNA quantitatively.Leuk Lymphoma,2001,42:225 -229.
  • 6Cilloni D,Saglio G.WT1 as a universal marker for minimal residual disease detection and quantification in myeloid leukemias and in myelodysplastic syndrome.Acta Haemato1,2004,112:79-84.
  • 7Ariyaratana S,Loeb DM.The role of the Wilms' tumour gene (WT1) in normal and malignant haematopoiesis.Expert Rev Mol Med,2007,9:1-17.
  • 8Nyvold CG,Stentoft J,Braendstrup K,et al.Wilms' tumor 1 mutation accumulated during therapy in acute myeloid leukemia:Biological and clinical implications.Leukemia,2006,20:2051-2054.
  • 9Iwasaki T,Sugisaki C,Nagata K,et al.Wilms' tumor 1 message and protein expression in bone marrow failure syndrome and acute leukemia.Pathol Int,2007,57:645-651.
  • 10Hollink IH,van den Heuvel-Eibrink MM,Zimmermann M,et al.Clinical relevance of Wilms' tumorl gene mutations in childhood acute myeloid leukemia.Blood,2009,113:5951-5960.

共引文献15

同被引文献42

引证文献14

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部